Reviewed by:
Prescription required
Doxazosin is a prescription medication used to treat high blood pressure and symptoms of benign prostatic hyperplasia (BPH). It relaxes blood vessels to improve circulation and reduces muscle tension in the prostate and bladder neck to ease urination. Doxazosin lowers blood pressure, reducing the risk of heart attack, stroke, and kidney problems, while improving urinary flow in men with BPH. It must be taken exactly as prescribed, with the first dose typically at bedtime to prevent dizziness or fainting from a sudden drop in blood pressure. Patients should stand up slowly to minimize lightheadedness.
Ready to Fill
Doxazosin
Cardura, Cardura XL
Alpha-1 adrenergic blocker (antihypertensive / BPH treatment)
Not a controlled medication
Tablets (immediate-release, extended-release)
For hypertension, doxazosin is typically started at 1 mg once daily, usually at bedtime, with gradual increases to 2–8 mg once daily as needed. In benign prostatic hyperplasia (BPH), treatment also begins at 1 mg once daily, with titration to 4–8 mg once daily based on response. When using the extended-release formulation (Cardura XL), dosing commonly starts at 4 mg once daily with breakfast, with a maximum dose of 8 mg daily.
Basics
Doxazosin is a prescription medication classified as an alpha-1 adrenergic blocker. It is primarily used to treat high blood pressure (hypertension) and to relieve urinary symptoms associated with benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate. By blocking alpha-1 receptors in blood vessels and the smooth muscle of the prostate and bladder neck, doxazosin relaxes these tissues.
In the cardiovascular system, this leads to widening of blood vessels, improved blood flow, and reduced blood pressure. In the urinary tract, it helps ease urine flow and reduces symptoms such as difficulty starting urination, a weak stream, and frequent nighttime urination.
While doxazosin does not cure hypertension or BPH, it plays an important role in long-term symptom control and risk reduction associated with elevated blood pressure.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Cardura is the brand-name formulation of doxazosin, containing doxazosin as its active ingredient. As a selective alpha-1 adrenergic receptor antagonist, Cardura works by targeting receptors located mainly in peripheral blood vessels and the lower urinary tract.
This mechanism produces two main therapeutic effects: lowering blood pressure through peripheral vasodilation and relieving BPH-related urinary symptoms by reducing resistance at the bladder neck and prostate.
Cardura is not a beta blocker, ACE inhibitor, calcium channel blocker, or diuretic, and it does not directly reduce heart rate or cardiac contractility. Its primary cardiovascular effect is a decrease in vascular resistance, although mild changes in heart rate may occur in some patients.
Indications
Cardura serves multiple therapeutic purposes by targeting and relaxing specific muscles and vessels. Its primary and secondary uses reveal its versatility and the array of conditions for which it can be beneficial.
Although primarily prescribed for the conditions above, doxazosin has properties that have made it useful for other conditions not approved by regulatory bodies. These off-label uses include:
Patients should discuss their conditions thoroughly with healthcare providers to determine whether doxazosin is an appropriate option for their specific health circumstances.
Mechanism
Understanding the mechanism of action and pharmacokinetics of Cardura involves delving into how the drug exerts its therapeutic effects after administration.
Cardura functions by antagonizing alpha-1 adrenergic receptors, which are located in the smooth muscle of blood vessels and the lower urinary tract (including the prostate and bladder neck).
When alpha-1 receptors are stimulated by endogenous catecholamines (like norepinephrine), smooth muscle contracts. By blocking these receptors, doxazosin produces smooth muscle relaxation:
Unlike some other antihypertensives, Cardura does not primarily act on the central nervous system, and its direct effect on heart rate is generally modest.
After oral administration:
Doxazosin is extensively metabolized hepatically, primarily via CYP3A4 (with contributions from other CYP pathways), and metabolites are excreted mainly in the feces, with a lesser amount in the urine.
Its terminal elimination half-life is about 22 hours, supporting once-daily dosing and relatively stable plasma levels over 24 hours.
Dosage
Cardura’s dosing is guided by the specific condition being treated and the patient’s response to therapy. Detailed dosing strategies and administration guidelines ensure that the medication’s benefits are maximized while minimizing side effects.
The medication’s pharmacokinetic profile supports once-daily dosing. Following oral administration, bioavailability is approximately 65% due to first-pass hepatic metabolism, and the terminal elimination half-life is approximately 22 hours. This relatively long half-life allows for stable blood levels with consistent daily use in both hypertension and BPH treatment.
For patients on extended-release (Cardura XL), the typical starting and target doses differ, and this formulation is typically limited to BPH treatment.
If Cardura is stopped for several days, guidelines recommend restarting at the initial 1 mg dose and re-titrating, due to the risk of “first-dose” hypotension recurring.
Cardura is taken orally, once daily, with or without food. Taking it at the same time each day helps maintain steady blood levels and simplifies adherence. The first dose—and subsequent dose increases—are often given at bedtime to reduce the chance of dizziness or fainting from sudden blood pressure drops when standing.
Tablets should be swallowed whole with a glass of water. Patients should avoid crushing or chewing tablets unless specifically instructed, as this can alter absorption.
The “Ghost Tablet” Phenomenon: Patients prescribed Cardura XL (extended-release) may notice an intact tablet in their stool after a bowel movement. This is a normal and expected effect of the drug’s non-absorbable extended-release delivery system (GITS), which gradually releases the medication as the outer shell passes through the digestive tract unchanged. The active medication has already been absorbed—do not take an extra dose if you observe this “ghost tablet.”
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Like any medication, Cardura presents a range of side effects, varying from common, non-serious reactions to rare but potentially severe outcomes. Awareness and understanding of these side effects can help patients and healthcare providers effectively manage and mitigate risks.
Patients taking Cardura commonly report several side effects; the most frequent among them include:
These effects often improve as the body adapts or after dose adjustment. Patients should report persistent or bothersome symptoms so the regimen can be reviewed.
While rare, serious side effects associated with Cardura can occur and require prompt medical attention:
Prompt recognition and treatment of serious side effects is crucial to prevent complications. Patients should seek emergency or urgent care if these occur, and physicians may adjust or discontinue Cardura as appropriate.
Interactions
Understanding the potential interactions between Cardura and other medications is essential to prevent adverse effects and ensure efficacy. Interactions can range from those involving other medications to lifestyle factors that might affect the drug’s performance.
Cardura has several notable drug interactions that need careful monitoring and management:
Cardura is primarily metabolized by CYP3A4; therefore, strong inhibitors or inducers of this enzyme could alter doxazosin levels. In practice, dose adjustments are guided by clinical efficacy and adverse-effect profiles.
In addition to pharmacological interactions, certain lifestyle factors can influence the effectiveness and safety of Cardura:
Patients should supply their healthcare providers with comprehensive lists of all medications they are taking, including over-the-counter drugs and supplements, to facilitate informed decisions regarding potential interactions.
Contraindications
While Cardura is generally regarded as safe for most individuals, certain conditions preclude its use. Contraindications and precautions ensure its proper use and help prevent adverse effects from inappropriate administration of the medication.
Cardura should not be used in patients with specific contraindications, including:
Beyond absolute contraindications, specific patient populations must exercise caution:
Before prescribing Cardura, healthcare providers should conduct thorough assessments to identify predisposing factors that may increase the risk of adverse effects associated with its use. The goal is to ensure that benefits significantly outweigh potential risks, and, when necessary, to consider alternative treatments to accommodate specific patient needs.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?